AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2022
Apr 1, 2022
35038_dirs_2022-04-01_6913b28a-d0f6-4641-8200-42b0f0094dbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2022-03-31
Reporting Person: Romano Kelly A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | Common Stock | P | 8000 | $13.11 | Acquired | 8315 | Direct |
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 20
Regulatory Filings
2026
Jan 20